Cargando…
Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?
Since the first detection of SARS-CoV-2 in China, COVID-19 (Corona Virus Disease 2019) has taken the lives of more than six million people. Although some antivirals seem proper for treatment, the investigation of finding the best therapeutic approach for COVID-19 is still continuing. Some observatio...
Autores principales: | Hosseini, Mahnaz Sadat, Davoudi-Monfared, Effat, Najmeddin, Farhad, Mojtahedzadeh, Mojtaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066957/ https://www.ncbi.nlm.nih.gov/pubmed/37004651 http://dx.doi.org/10.1007/s41030-023-00220-4 |
Ejemplares similares
-
Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report
por: Shahrami, Bita, et al.
Publicado: (2022) -
LipoxinA4 as a Potential Prognostic Marker of COVID-19
por: Jamali, Farzaneh, et al.
Publicado: (2022) -
Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
por: Davoudi-Monfared, Effat, et al.
Publicado: (2021) -
Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
por: Shahrami, Bita, et al.
Publicado: (2020) -
Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)